FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3016574598> ?p ?o ?g. }

• W3016574598 endingPage "1249" @default.
• W3016574598 startingPage "1241" @default.
• W3016574598 abstract "Abstract Patients with newly diagnosed chronic phase chronic myeloid leukemia (CP CML) can be effectively treated with tyrosine kinase inhibitors (TKIs) and achieve a lifespan similar to the general population. The success of TKIs, however, requires long-term and sometimes lifelong treatment; thus, patient-assessed health-related quality of life (HRQoL) has become an increasingly important parameter for treatment selection. Bosutinib is a TKI approved for CP CML in newly diagnosed adults and in those resistant or intolerant to prior therapy. In the Bosutinib Trial in First-Line Chronic Myelogenous Leukemia Treatment (BFORE), bosutinib demonstrated a significantly higher major molecular response rate compared with imatinib, with maintenance of HRQoL (measured by the Functional Assessment of Cancer Therapy-Leukemia (FACT-Leu) questionnaire), after 12 months of first-line treatment. We examined relationships between molecular response (MR) and HRQoL. MR values were represented by a log-reduction scale (MRLR; a continuous variable). A repeated-measures longitudinal model was used to estimate the relationships between MRLR as a predictor and each FACT-Leu domain as an outcome. Effect sizes were calculated to determine strength of effects and allow comparisons across domains. The majority of FACT-Leu domains (with the exception of social well-being and physical well-being) demonstrated a significant relationship with MRLR ( p < 0.05). Our results showed variable impact of clinical improvement on different dimensions of HRQoL. For patients who achieved MR 5 , emotional well-being and leukemia-specific domains showed the greatest improvement, with medium differences in effect sizes, whereas social well-being and physical well-being had the weakest relationship with MR." @default.
• W3016574598 created "2020-04-24" @default.
• W3016574598 creator A5002753518 @default.
• W3016574598 creator A5029270472 @default.
• W3016574598 creator A5031955903 @default.
• W3016574598 creator A5036874214 @default.
• W3016574598 creator A5044355331 @default.
• W3016574598 creator A5087641723 @default.
• W3016574598 creator A5090399884 @default.
• W3016574598 creator A5091669022 @default.
• W3016574598 date "2020-04-19" @default.
• W3016574598 modified "2023-09-23" @default.
• W3016574598 title "Relationship between molecular response and quality of life with bosutinib or imatinib for chronic myeloid leukemia" @default.
• W3016574598 cites W1492075988 @default.
• W3016574598 cites W1968747503 @default.
• W3016574598 cites W1977733462 @default.
• W3016574598 cites W1984698679 @default.
• W3016574598 cites W1999494567 @default.
• W3016574598 cites W2013450609 @default.
• W3016574598 cites W2035161645 @default.
• W3016574598 cites W2044966465 @default.
• W3016574598 cites W2062448901 @default.
• W3016574598 cites W2064130198 @default.
• W3016574598 cites W2082269822 @default.
• W3016574598 cites W2097799776 @default.
• W3016574598 cites W2104847866 @default.
• W3016574598 cites W2117356576 @default.
• W3016574598 cites W2129382787 @default.
• W3016574598 cites W2143116594 @default.
• W3016574598 cites W2143939343 @default.
• W3016574598 cites W2148743957 @default.
• W3016574598 cites W2164872817 @default.
• W3016574598 cites W2192004321 @default.
• W3016574598 cites W2333084365 @default.
• W3016574598 cites W2343511371 @default.
• W3016574598 cites W2473480037 @default.
• W3016574598 cites W2552390840 @default.
• W3016574598 cites W2558018455 @default.
• W3016574598 cites W2571233568 @default.
• W3016574598 cites W2594879565 @default.
• W3016574598 cites W2766175045 @default.
• W3016574598 cites W2766187515 @default.
• W3016574598 cites W2790536087 @default.
• W3016574598 cites W2791864061 @default.
• W3016574598 cites W2802371729 @default.
• W3016574598 cites W2804990894 @default.
• W3016574598 cites W2887100667 @default.
• W3016574598 cites W2889580406 @default.
• W3016574598 cites W2911105557 @default.
• W3016574598 cites W2937928400 @default.
• W3016574598 cites W2941714453 @default.
• W3016574598 cites W4255713912 @default.
• W3016574598 doi "https://doi.org/10.1007/s00277-020-04018-1" @default.
• W3016574598 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7237399" @default.
• W3016574598 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32307568" @default.
• W3016574598 hasPublicationYear "2020" @default.
• W3016574598 type Work @default.
• W3016574598 sameAs 3016574598 @default.
• W3016574598 citedByCount "8" @default.
• W3016574598 countsByYear W30165745982020 @default.
• W3016574598 countsByYear W30165745982021 @default.
• W3016574598 countsByYear W30165745982022 @default.
• W3016574598 countsByYear W30165745982023 @default.
• W3016574598 crossrefType "journal-article" @default.
• W3016574598 hasAuthorship W3016574598A5002753518 @default.
• W3016574598 hasAuthorship W3016574598A5029270472 @default.
• W3016574598 hasAuthorship W3016574598A5031955903 @default.
• W3016574598 hasAuthorship W3016574598A5036874214 @default.
• W3016574598 hasAuthorship W3016574598A5044355331 @default.
• W3016574598 hasAuthorship W3016574598A5087641723 @default.
• W3016574598 hasAuthorship W3016574598A5090399884 @default.
• W3016574598 hasAuthorship W3016574598A5091669022 @default.
• W3016574598 hasBestOaLocation W30165745981 @default.
• W3016574598 hasConcept C121608353 @default.
• W3016574598 hasConcept C126322002 @default.
• W3016574598 hasConcept C143998085 @default.
• W3016574598 hasConcept C159110408 @default.
• W3016574598 hasConcept C2776960273 @default.
• W3016574598 hasConcept C2777583451 @default.
• W3016574598 hasConcept C2778208673 @default.
• W3016574598 hasConcept C2778461978 @default.
• W3016574598 hasConcept C2778729363 @default.
• W3016574598 hasConcept C2778820342 @default.
• W3016574598 hasConcept C2779536868 @default.
• W3016574598 hasConcept C2779951463 @default.
• W3016574598 hasConcept C2908647359 @default.
• W3016574598 hasConcept C71924100 @default.
• W3016574598 hasConcept C99454951 @default.
• W3016574598 hasConceptScore W3016574598C121608353 @default.
• W3016574598 hasConceptScore W3016574598C126322002 @default.
• W3016574598 hasConceptScore W3016574598C143998085 @default.
• W3016574598 hasConceptScore W3016574598C159110408 @default.
• W3016574598 hasConceptScore W3016574598C2776960273 @default.
• W3016574598 hasConceptScore W3016574598C2777583451 @default.
• W3016574598 hasConceptScore W3016574598C2778208673 @default.
• W3016574598 hasConceptScore W3016574598C2778461978 @default.
• W3016574598 hasConceptScore W3016574598C2778729363 @default.
• W3016574598 hasConceptScore W3016574598C2778820342 @default.

• next